Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Tolerability and Efficacy of a Combination of Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01855360
Recruitment Status : Completed
First Posted : May 16, 2013
Last Update Posted : June 20, 2017
Sponsor:
Information provided by (Responsible Party):
Rodney H. Falk, MD, Brigham and Women's Hospital

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : May 31, 2015
  Actual Study Completion Date : May 31, 2015
  Certification/Extension First Submitted : June 16, 2017
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 August 10, 2018
September 5, 2018
2 November 8, 2018
December 3, 2018